Thiogenesis Therapeutics, Corp. TTI.V
TSX
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 5.12M | 647.20K | 1.18M | 2.51M | 1.35M |
| Total Receivables | 37.80K | 18.90K | 56.00K | 48.90K | 35.60K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 56.60K | 71.50K | 89.10K | 39.40K | 35.50K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 5.22M | 737.60K | 1.32M | 2.60M | 1.42M |
|
|
|||||
| Total Current Assets | 5.22M | 737.60K | 1.32M | 2.60M | 1.42M |
| Net Property, Plant & Equipment | -- | -- | -- | -- | -- |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | -- | -- | -- |
| Total Assets | 5.22M | 737.60K | 1.32M | 2.60M | 1.42M |
|
|
|||||
| Total Accounts Payable | 482.70K | 893.60K | 904.80K | 1.05M | 1.09M |
| Total Accrued Expenses | -- | 6.30K | -- | 6.10K | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Current Liabilities | -- | -- | -- | -- | -- |
| Total Current Liabilities | 482.70K | 899.90K | 904.80K | 1.06M | 1.09M |
|
|
|||||
| Total Current Liabilities | 482.70K | 899.90K | 904.80K | 1.06M | 1.09M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 482.70K | 899.90K | 904.80K | 1.06M | 1.09M |
|
|
|||||
| Common Stock & APIC | 19.78M | 14.27M | 14.53M | 14.30M | 11.89M |
| Retained Earnings | -16.98M | -16.21M | -15.83M | -14.34M | -12.90M |
| Treasury Stock & Other | 1.94M | 1.77M | 1.72M | 1.59M | 1.35M |
| Total Common Equity | 4.73M | -162.30K | 418.90K | 1.55M | 335.00K |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 4.73M | -162.30K | 418.90K | 1.55M | 335.00K |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 4.73M | -162.30K | 418.90K | 1.55M | 335.00K |
|
|
|||||